In the midcap space, the list found names such as Vodafone Idea, India Cements, Godrej Consumer Products, Glenmark Pharmaceuticals, Havells India, M&M Financial Services, Ambuja Cements, PNB Housing Finance, L&T Technology Services, IRCTC, LTIMindtree, Vedanta, Tata Power. These stocks have risen ov…

Somersault action! 631 stocks give multibagger returns since Covid, 34 part of Nifty50

The drug maker said that it has received final approval from US Food & Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%, 0.064%.

Glenmark Pharma gets USFDA nod for two drugs

Glenmark Pharma has received final approval from the US Food & Drug Administration (USFDA) for Calcipotriene and Betamethasone Dipropionate Foam, the generic version of Leo Pharma’s Enstilar

Glenmark gets USFDA nod for generic drug with 180-day exclusivity

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to market a generic product used to treat schizophrenia and in some cases to control severe nausea.

Glenmark gets USFDA nod to market generic medication to treat schizophrenia

Glenmark Pharmaceuticals said that it has received final approval by the United States Food & Drug Administration (US FDA) for Prochlorperazine Maleate tablets, the generic version of Compazine tablets of GlaxoSmithKline.

Glenmark Pharma gets US FDA nod for generic Prochlorperazine tablets

Glenmark’s Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA.

Glenmark receives USFDA approval for Prochlorperazine Maleate Tablets

Glenmark Pharmaceuticals Ltd is quoting at Rs 440.6, up 1.86% on the day as on 12:49 IST on the NSE. The stock is down 3.32% in last one year as compared to a 0.67% slide in NIFTY and a 13.39% slide in the Nifty Metal index.

Glenmark Pharmaceuticals Ltd rises for third straight session

Glenmark Specialty SA, a subsidiary of the company received acceptance from the US drug regulator for first-in-human clinical study for treatment of patients with advanced solid tumors and lymphomas.

Glenmark Pharma arm gets USFDA nod for human trial of cancer drug

TCS, Dr Reddy’s Lab, Eris Lifesciences, Glenmark Pharma, RVNL, Lemon Tree Hotels, IndiaMart InterMesh, Samvardhana Motherson, Shri Keshav Cement, Quint Digital, Jubilant Ingrevia and Vishvprabha Foods are some of the stocks that are likely to be in action today

stocks in action today

The derivative analyst from HDFC Securities recommends to Buy Glenmark Pharma 440 CALL at Rs 7 & simultaneously sell 450 CALL at Rs 4 of March series

Nandish Shah recommends Bull Spread on Glenmark Pharma for March series

Stocks to watch today: From TCS to Patanjali Foods, here are stocks to watch out in Friday’s trading session

Stocks to watch: TCS, Patanjali Foods, Glenmark Pharma, Vi, DLF, Eris Life

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).

Glenmark Pharmaceuticals Ltd